ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.395
0.00%
US Dollar vs AUD
1.51745
0.00%
Bitcoin
69,383.44
0.07%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Frequency Therapeutics Inc (FREQ)

  7. Frequency Therapeutics Inc (FREQ) News

FREQ

Frequency Therapeutics (FREQ)

Frequency Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FREQ
DateTimeSourceHeadlineSymbolCompany
02/05/202407:18Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FREQFrequency Therapeutics Inc
29/04/202421:47Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:FREQFrequency Therapeutics Inc
29/04/202421:44Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FREQFrequency Therapeutics Inc
29/04/202421:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
27/04/202406:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FREQFrequency Therapeutics Inc
25/04/202409:33Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
25/04/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
25/04/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
25/04/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
24/04/202407:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
23/04/202407:14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
23/04/202407:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
20/04/202406:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
18/04/202422:52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
18/04/202422:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
29/03/202406:20Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
28/03/202415:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FREQFrequency Therapeutics Inc
27/03/202408:09Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FREQFrequency Therapeutics Inc
27/03/202408:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FREQFrequency Therapeutics Inc
27/03/202407:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
27/03/202407:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FREQFrequency Therapeutics Inc
07/11/202309:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FREQFrequency Therapeutics Inc
07/11/202309:22Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FREQFrequency Therapeutics Inc
07/11/202300:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
03/11/202307:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FREQFrequency Therapeutics Inc
26/10/202307:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FREQFrequency Therapeutics Inc
13/10/202307:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FREQFrequency Therapeutics Inc
02/10/202315:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FREQFrequency Therapeutics Inc
30/09/202306:14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
28/09/202320:06Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FREQ

Your Recent History

FX
AUDCAD
AUD vs CAD
ASX
AMP
AMP
NASDAQ
AAPL
Apple
ASX
BHP
BHP
NYSE
MRK
Merck
ASX
WPL
Woodside Petroleum
ASX
WOW
Woolworths
ASX
SUN
Suncorp
COIN
ETHUSD
Ethereum
ASX
FMG
Fortescue
NASDAQ
NVDA
NVIDIA
NYSE
NKE
Nike
ASX
RIO
Rio Tinto
ASX
QBE
QBE Insurance
ASX
ANZ
Australia And New Zealan...
ASX
WDC
Westfield
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved